Teva 2024 Healthy Future Report
Healthy People
Teva launched two new access to medicines programs—one in El Salvador and a global emergency stockpile—for a total of nine, surpassing its target of eight programs by 2025. Through these nine programs, Teva donated ~18 million doses of medicine, worth $23 million, and provided 2.2 million doses at low cost, reaching 187,000 patients. Five programs also focus on health systems strengthening and capacity building and benefitted ~56,000 individuals.
Healthy Planet
Teva achieved a 29% reduction in absolute scope 1 and 2 greenhouse gas (GHG) emissions from 2019 levels, surpassing its target of 25% by 2025 ahead of schedule. Additionally, 73% of applicable Teva sites achieved safe discharge levels of antibiotics, minimizing environmental pollution and supporting public health. Through a new antimicrobial resistance capacity-building pilot program in Germany, the Company educated more than 65,000 healthcare professionals, leading to approximately 389,000 patient interactions about appropriate use of antibiotics.
Healthy Business
Operating with integrity helps Teva mitigate risk and build trust with its stakeholders. More than 99% of employees were retrained on compliance and ethics and Teva’s Code of Conduct, achieving its annual target and reinforcing a culture of accountability and ethical decision-making. 41% of significant suppliers were evaluated for sustainability performance, and 100% of high-risk third-party business partners were evaluated through Teva’s Third-Party Due Diligence tool, ensuring responsible sourcing practices and reducing risks across its supply chain.
“Healthy Future is closely connected to our Pivot to Growth strategy, designed to support long-term growth and resilience” said Richard Francis, Teva’s President and CEO. “Our 2024 Healthy Future report shares how we’re advancing the topics most closely tied to our business, strengthening our company while continuing to better health worldwide—to create the future we want to see.”
View the full Teva 2024 Health Future Report.
